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ABSTRACT 
Herein, I optimize a method for synthesis and bioconjugation of water-soluble, 
fluorescent CdSe/ZnS quantum dots (QDs) for targeted cellular delivery of DNA. Core 
CdSe QDs were synthesized in high temperature organic solvents and passivated with a 
ZnS shell to increase quantum yield. The fluorescent QD nanoparticles were made water-
soluble by enveloping them with an amphiphilic polymer. These aqueous nanoparticles 
were functionalized with tertiary amines to impart a positive charge, allowing 
electrostatic binding to negatively-charged DNA. The conjugated QDs were 
characterized using zeta potential and electrophoresis to gauge their ability to 
electrostatically bind DNA. The QDs were further modified by conjugation with Wheat 
Germ Agglutinin (WGA) (a carbohydrate-binding protein) in an aim to direct 
nanoparticle trafficking within the cell. I observed the effect of this conjugation to QDs in 
N2a (mouse neuroblastoma) cells using fluorescence microscopy and 
immunocytochemistry to visualize trafficking. The images were used to evaluate the 
potential of bioconjugated QDs as a targeted non-viral gene therapy vector. 
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CHAPTER 1: INTRODUCTION 
 
1.1 What are Quantum Dots? 
Quantum Dots (QDs) are semiconductor nanocrystals made of group II and IV 
(e.g. cadmium and selenium) or group III and V (e.g. indium and phosphorus) elements 1 
.The attraction of these nanoparticles is their unique ability to fluoresce in various 
controllable colors based on their size, as well as superior photostability. Recent advances 
have looked into surface modification of these QDs for various applications in 
biomedical research, diagnostics, therapeutics, batteries, solar cells, and many other areas 
2, 3. The ability to tailor QD functionality, along with their increased resistance to 
photobleaching compared to traditional organic dye, make them a very attractive 
alternative in biological applications. QDs have an intense fluorescence and a distinctive 
blinking pattern that can allow for single molecule imaging and tracking within a cell 4. 
The key to these superior characteristics lies in the core structure of the quantum dot. 
The fluorescent characteristics of QDs that make them unique stems from their 
size. Typical CdSe QDs range in size from ~2 to 5 nm depending on the fluorescence 
emission color desired. At this size, the QD exhibits a physical size that is smaller than 
the exciton Bohr radius. The Bohr radius is the spatial distance between an electron and 
the hole left behind after excitation 5.  The difference between the Bohr radius of the QD 
and physical size results in a quantum confinement effect. That is, electrons exist in 
discrete energy levels instead of continuous energy levels of bulk materials. This 
confinement causes the smallest band gap to increase in energy as the particle decreases 
in size, resulting in the emission of higher energy photons 1. The energy of emitted 
2 
photons determines the fluorescence emission color (i.e. wavelength). The wavelength of 
fluorescence emission directly relates to QD size. A red shift occurs as QD size increases 
and band gap decreases (Figure 1.1). 
 
 
Figure 1.1. The Energy Relationship Between QD Size and Fluorescence Emission Color 
6. QD size is directly proportional to wavelength of the emitted photon. Quantum 
confinement results in discrete energy levels. The difference between the two energy 
levels (i.e. valence and conduction bands) increases as QD size decreases. This increase 
in band gap energy decreases the wavelength of the emitted photon, appearing as a blue-
shift in fluorescence emission. 
 
The small size of QDs allows for delocalization of the electrons around the 
nanocrystal. When electrons are irradiated with UV light an exciton pair is generated. An 
exciton pair is an excited electron and the partially positive “hole” left behind. Under 
normal circumstances an electron will recombine with the hole, which results in an 
emission of a photon. This is called radiative relaxation. If an excited electron is free to 
move around the nanocrystals, it can relax through non-radiative processes. Non-radiative 
processes include vibrational and rotational energy modes that relax an electron without 
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the release of a photon. If an electron relaxes through non-radiative processes, it may no 
longer recombine with the hole, causing a surface defect, or a trap state. Trap states 
effectively decrease the fluorescence and quantum yield of QDs. While trap states are 
detrimental to the quality of the core, there are methods to help prevent loss of 
fluorescence 7. The main method is addition of a coating onto the outside of the core to 
help prevent surface defects. The addition of a coating results in what is called a core-
shell system (Figure 1.3). Coating QDs requires careful characterization of the cores to 
optimize core-shell quality. 
Core quality can be quickly determined through the use of fluorescence spectra. 
Fluorescence spectra can indicate the size distribution of QDs in solution. The peak width 
in a fluorescence spectrum is indicative of the QD size distribution. A typical synthesis of 
high-quality CdSe QDs has a fluorescence emission peak with a full width at half 
maximum (FWHM) range of 25 +/- 2 nm 8. The typical width in this work was 26-30 nm. 
The narrow size distribution of these QDs is obtained by carefully controlling 
reactants and limiting nucleation and growth times. While large (~5-6 nm) QDs are easier 
to synthesize than small QDs, creating large-sized QDs with a narrow size distribution is 
challenging due to Ostwald’s ripening. Ostwald ripening is a thermodynamically driven 
process by which smaller particles dissolve and deposit onto larger particles, effectively 
widening the size distribution of nanoparticles 9. When the concentration of a precursor 
falls below nucleation levels, Ostwald’s ripening can occur during QD synthesis. Smaller 
nucleated crystals dissolve and larger crystals grow resulting in a wider size distribution. 
This is evident in the FWHM of a fluorescence spectrum. To control Ostwald’s ripening, 
precursor solutions and reaction times are meticulously monitored during synthesis. This 
4 
minimizes the size distribution, which allows for more accurate calculation of QD 
concentration and diameter.  
The diameter, in nanometers, of a given solution of CdSe particles can be 
calculated with the first exciton absorption peak (λ) in nm. This equation is derived from 
experimental data provided by W. W. Yu et al 8 and covers a range of excitation peaks λ 
from 300 to 700 nm. For our synthesis, the first excitonic peak typically fell between 
630-650 nm; therefore, this equation is applicable to our QD products. The equation uses 
the first exciton absorption peak (λ in nm) and can be seen here: 
 𝐷 = 1.6122𝑥10!! 𝜆! − 2.6575𝑥10!! 𝜆! + 1.6242𝑥10!! 𝜆! − 0.4277 𝜆 + 41.57 
 
 
Once the diameter is calculated, the extinction coefficient can be calculated based 
on a size-dependent equation also modeled by W. W. Yu et. al.. This equation uses the 
diameter previously calculated and can be seen here: 
 𝜀 = 5857  (𝐷)!.!" 
 
The extinction coefficient can then be used to calculate the concentration of each 
sample solution using the Beer-Lambert Law (A=εbc). That is, the absorption value (A) 
at the same λ used in Equation 1.1 is equal to the extinction coefficient (ε) multiplied by 
the path length of the cuvette (b) and the concentration of the sample (c). It is important 
to note that the FWHM of the peak can invalidate diameter calculations if it is profoundly 
wider than 25 nm. It is notable that different ligands (e.g. Tiroctylphosphine oxide, 
5 
pyridine, and many thiols) bound to the QD surface are reported to have little to no effect 
on the calculation of the extinction coefficient 8. The QD concentration and diameter was 
used to determine the amount of Zn and S needed to coat effectively in the next synthesis 
step (i.e. ZnS Coating). 
One concern of CdSe core integrity is the potential of degradation upon exposure 
to atmospheric oxygen. While short periods (<10 min) of exposure to air did not result in 
noticeable decreases in QD quality, longer times can result in oxidation and degradation 
of the CdSe QD cores into CdO and SeO2 (Figure 1.2). To prevent this degradation, ZnS 
is added as a shell coating.  
The ZnS shell is added as quickly as possible after core synthesis to avoid 
oxidation 10. A ZnS layer of at least 1.3 monolayers (MLs) has been shown in previous 
work to be the minimal coating to prevent degradation. Up to four additional ZnS MLs 
were added to increase the quantum yield and fluorescence intensity  11. More than four 
MLs has been shown to decrease the fluorescence and quantum yield 12. 
The addition of a shell is a commonly used method to increase fluorescence 
intensity and protect cores from degradation over time. In many cases, increases in 
quantum yield have been shown to be as much as ten times the yield of non-shell coated 
cores 5. When choosing the identity of the shell, a small lattice mismatch between cores 
(CdSe) and shells (ZnS) is the key to an effective shell coating. This mismatch allows the 
shell system to evenly coat the core without disrupting the lattice of the core system. The 
band gap difference of the shell can be adjusted to control where electrons are most likely 
to recombine in the core-shell system. Relaxation of electrons can be isolated within the 
core, within the shell, or within the core-shell interface, depending on the type of shell 
6 
system used.  
 
 
Figure 1.2. Oxidation of CdSe Cores. 13 Prolonged exposure of CdSe nanocrystals to 
oxygen in the atmosphere can lead to degradation. This degradation is observable as a 
blue shift in fluorescence emission (i.e. from bright red to yellow or orange fluorescence). 
Prolonged exposure can lead to complete quenching of fluorescence. 
 
 
The band gaps of cores and shells can be selected to tailor the lowest energy 
recombination to the area of interest. Confinement of electrons to the core can be chosen 
by selecting a shell with an increased band gap compared to the core. Increasing the band 
gap of the shell causes electrons to recombine within the core. This is what is referred to 
as the Type I core-shell system. CdSe-ZnS QDs (the focus of this work) are examples of 
type I core-shell systems. Spatially confining electrons within the core decreases 
relaxation through non-radiative processes. Other core-shell types (Figure 1.3) include 
Type II, in which the valence and conduction band of the shell are either above or below 
their respective bands in the core. This results in an isolation of electrons within the core-
shell interface. Reverse Type I core-shell systems have a smaller band gap in the shell 
7 
than the core. This causes an isolation of electrons within the shell instead of the core. 
 
 
Figure 1.3. Core-Shell System Types 3. Core-shell system types confine electrons to a 
specific region within the QD structure.This is done by adjusting the core band gap 
(Blue) and the shell band gap (Red). This can increase the quality of the QD by isolating 
the ability of an electron to recombine, which may decrease trap states. 
 
 
 
Another layer of complexity to QD structure is the characteristic interaction of 
organic ligands with the surface. A multitude of ligands, such as trioctylphosphine oxide 
(TOPO), tetradecylphosphionc acid (TDPA), and dithiol compounds, are used to impart 
specific functionality or stability 14. Ligands bind to the outside of the shell through dative 
bonds. This bond with the surface of the QD core is formed through oxygen, sulfur or 
another electronegative element of the ligand 10. The ligands also contain hydrophobic 
moieties that interact with organic solvents, typical of QD synthesis conditions. These 
hydrophobic moieties limit the utility of QDs by restricting the QDs to non-polar 
solvents. Consequently, further modification is needed before QDs can be used in living 
systems. 
Modifications to impart QDs with water solubility must be made before they can 
be applied in most living systems. To this end, there are three major techniques used: 
ligand exchange, surface silanization, and coating with amphiphilic polymers. Each of 
these techniques has advantages and shortcomings in regard to stabilization, overall size, 
8 
or ease of functionalization.  
 A popular technique to impart water solubility to QDs is ligand exchange. Ligand 
exchange works by thermodynamic competition between two ligands for surface binding. 
Trioctylphosphine oxide (TOPO) is a common ligand of QD cores since it is a byproduct 
of core synthesis. However, when more stable ligands compete for shell interaction, 
TOPO can be replaced 15. Many thiols are commonly used for ligand exchange with 
TOPO. Compounds containing multiple thiol groups (such as dihydrolipoic acid, Figure 
1.4) can datively bind to the shell multiple times from a single ligand (i.e. multivalent), 
increasing stability 16. Ligand exchange may suffer from decreased stability in water 
compared to other water solubilization methods. This is the result of the hydrolysis of 
ligands over time, leading to dissociation from the QD surface. Current work in other 
projects in our lab are attempting to increase the stability of ligand-QD associations by 
using multiple dative bonds through a single ligand 16. 
 
 
Figure 1.4. Surface Interaction of Bidentate Thiol Ligands. Ligand exchange methods 
attempt to increase the surface interactions of many ligands by creating multiple dative 
bonds to the surface. 
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 A second method to impart water solubility is surface silanization. This method 
uses compounds containing trimethoxysilane groups that can be cross-linked to form 
siloxane bonds to create a shell that can be further functionalized 16. This type of shell 
network is much more stable for long-term storage than ligand exchange. However, this 
extensive shell increases QD size more than stabilization via an amphiphilic polymer or 
ligand exchange methods 16. Silanization also requires much more intensive procedural 
considerations than ligand exchange or amphiphilic polymer interactions.  
Amphiphilic polymer interactions are the newest of the three common techniques 
used to impart water solubility to QDs. This method relies on hydrophobic/hydrophilic 
interactions between the polymer and the ligand coating the surface of the CdSe/ZnS 
core-shell. The three branching long carbon chains of the TOPO ligand interact with the 
hydrophobic portion of the amphiphilic polymer. The result is a micelle-like structure 
(Figure 1.5) that imparts water solubility to the QD with hydrophilic functional groups on 
the outside of the polymer. This method is much less labor intensive than the silanization, 
while maintaining resistance to enzymatic degradation and hydrolysis 17. The amphiphilic 
polymer can be chosen to contain chemical moieties for future bioconjugation. 
Amphiphilic polymer interaction was chosen as the water solubility method in this work 
for its longer stability times vs. ligand exchange and small size vs. surface silanization. 
10 
 
Figure 1.5. Interaction of an Amphiphilic Polymer with a QD Surface. The hydrophobic 
chains of the amphiphilic polymer integrate with the hydrophobic chains of the TOPO, 
which are datively bound to the QD surface. This exposes the hydrophilic moieties of the 
amphiphilic polymer as the new “coating”, imparting water solubility to the QD. 
 
 
1.2 Gene Therapy 
 Gene therapy has been the focus in many genetic disease treatments (e.g. severe 
combined immunodeficiencies, SCIDs) within the past few decades 18. The main goal of 
gene therapy is to treat diseases that are the result of a genetic disorder, mutated genes, or 
faulty/missing proteins. Gene therapy inserts the missing or functional version of the 
gene into the cell and replaces the mutated or missing one. Viral gene therapy in 
particular has been shown to be one of the most efficient methods 18. However, non-viral 
techniques are being developed because of the safety concerns of viral techniques 18.  
Viral gene therapy can be an extremely effective technique that has improved the 
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treatment of diseases, such as SCIDs, by modifying a virus to insert therapeutic DNA. 
This success has been achieved in some clinical trials by using a disabled retrovirus as a 
vector 18. This disabled virus can utilize its natural ability to efficiently deliver a gene to 
the nucleus. The common viruses used in gene therapy are the adenovirus, retrovirus, or 
herpes simplex virus 19. To ensure that viruses are safe for gene therapy they are 
genetically modified to remove or disrupt coding sequences that could cause dangerous 
side effects. In its first years, gene therapy looked very promising, but in 2002 patients 
receiving treatment in France developed leukemia-like symptoms 18. This caused a new 
wave of research and concern that ended with the realization that the virus was able to 
easily insert the therapeutic sequences. However, insertion can promote or disrupted 
many regulatory genes within the cell. In the case of the leukemia patients, the gene 
disrupted a sequence that affected apoptosis, leading to uncontrolled cell replication (i.e. 
cancer) 18.  Another disadvantage of viral gene delivery is the storage capabilities of the 
vector. Many viral vectors have a very limited capacity for carrying therapeutic DNA, 
meaning the larger therapeutic sequences may not fit within the viral capsid 20.  
Alternative non-viral methods (e.g. transfection via lipoplexes and polyplexes) 
have been developed to avoid many viral complications. The main goal of lipoplex or 
polyplex formation is to compact and protect therapeutic DNA from degradation during 
cellular delivery and intracellular trafficking to target locations. Lipoplexes (complexes 
between cationic lipids and anionic phosphate backbone of nucleic acid sequences) are 
micelle-like structures that can be functionalized for cellular interactions 21. Positively-
charged formations bind DNA through electrostatic interactions due to the negative 
charge of polyanionic DNA. A common example of a cationic lipid vector is the 
12 
commercial transfection reagent lipofectamine, which electrostatically complexes DNA 
to form a lipoplex 22. The lipoplex can fuse with the plasma membrane of cells to release 
DNA into the cytosol. While this is effective, transfection relies on the ability of DNA to 
enter the nucleus 21. However, lipofection remains the most common non-viral gene 
transfer technique used in clinical trials 23. 
In contrast to lipoplex formation, polyplexes utilize a cationic polymer for 
electrostatic binding and condensation of DNA. The resulting polyplex structure is 
amorphous. Polyplexes are generally able to condense DNA at a much higher efficiency 
that lipoplexes 21. As long as the polyplex maintains a net positive charge, it retains that 
ability to interact with the membrane of the cell 21. Polyplexes are often taken up by 
endocytosis to a larger degree than direct insertion through the plasma membrane. 
All non-viral methods have strengths and weaknesses, but shared challenges arise 
from how these vectors are intracellularly trafficked to the nucleus of the cell 24. Once 
internalized by the cell, vectors can go through many pathways that include clathrin-
mediated endocytosis, caveolae-mediated endocytosis, or macropinocytosis 24. 
Macropinocytosis is largely ignored in this work due to it internalizing primarily 
structures over 500 nm in size 24 .Clathrin and caveolin-mediated endocytosis are the 
primary trafficking pathways suspected for QD vectors. Clathrin-mediated endocytosis 
allows for specific contents to be internalized and is often triggered through specific 
receptor proteins on the plasma membrane of the cell. The protein that coats the outside 
of this type of vesicle is clathrin. Caveolin-mediated endocytosis is a less common 
mechanism of internalization that does not depend on clathrin, but instead caveolin. This 
pathway is known to be associated with the internalization of animal viruses 25. These 
13 
two endocytic pathways can lead to the Golgi apparatus and eventually into the nucleus 
through a hypothetical pathway proposed by Dr. Fichter (Figure 1.6). However, this 
pathway relies on the ability to avoid lysosomal degradation. If the contents are delivered 
to lysosomes, they will be subjected to a highly acidic environment and degradative 
enzymes that can digest therapeutic DNA. Many conjugates can go through both 
pathways, which can lead to significant lysosomal degradation unless a targeting domain 
is added to avoid the lysosome 26. With the addition of a targeting agent, non-viral vector 
contents could be targeted through early endosomes into the Golgi, from the Golgi to the 
endoplasmic reticulum, and from the endoplasmic reticulum into the nucleus. 
 
 
Figure 1.6. Potential Pathways of Non-Viral Gene Delivery. The goal of this work is to 
exploit a targeting molecule that can direct the therapeutic QD-DNA vector taken from 
the plasma membrane of the cell (PM) through the early endosome (EE) or caveolae (C), 
and into the Golgi apparatus. The Golgi can then traffick the contents through the 
endoplasmic reticulum (ER) and into the space between the inner and outer nuclear 
membrane, which is contiguous with the ER. The effectiveness of this technique hinges 
on the ability of the targeting molecule to avoid trafficking to lysosomes (L). Image 
obtained from Dr. Katye Fichter (manuscript in progress). 
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A main strategy to avoid lysosomes is conjugation of biomolecules to direct the 
vector once inside the cell, avoiding the lysosome entirely. To this end, many types of 
surface functionalization of QDs have been explored. This work focuses on attachment of 
a  protein, wheat germ agglutinin (WGA), to the QD surface for direction within the cell; 
along with the attachment of polyethyleneglycol (PEG) derivatives to reduce non-specific 
binding 27, 28. By attaching WGA and PEG we hope to avoid lysosomal degradation while 
directing the complex to the nucleus of the cell. 
 
1.3 Biological Applications of Quantum Dots 
Many fluorophores (organic dyes, fluorescently conjugated antibodies, or more 
recent fluorescent nanoparticles) are used to label structures within cells. Each of these 
probes have advantages and disadvantages considering imaging time, specificity, and 
application to living cells. These fluorescent markers can be used in conjunction with one 
another to create a more thorough view of the cell. 
While traditional organic dyes, like Hoechst, and DyLight™ are relatively small 
in size, they have limited photostability, which limits the effective imaging time 29. The 
fluorescence lifetime of most organic dyes are only around 5 ns, while QDs can attain 
100+ ns 30. This allows for more sensitive data to be obtained over longer imaging time 
periods 30. QDs also resist photobleaching, which allows imaging over the course of hours 
when properly utilized. Fluorophores like Hoechst and DyLight™ may quench within 
seconds upon exposure to irradiation. After ~10 min, in some cases, the fluorescence of 
these fluorophores can be completely quenched, making them inefficient for long-term 
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imaging. The use of QDs is a suitable alternative to avoid the photobleaching of organic 
dyes. 
Immunoglobulin G (IgG) antibodies have been used to selectively bind to proteins 
that are specific to organelles within cells. Their structure (seen in Figure 1.7) consists of 
Y shape formed by two heavy and two light chains of peptides. These chains form 
regions called the Fab and Fc regions. The Fab region is where the specific binding to an 
antigen takes place, while the Fc region is highly conserved among the same species. 
IgGs are harvested from sera of animals (mouse, rat, goat, horse, etc) treated with an 
antigen 31. For example, a rabbit anti-giantin antibody is a Golgi apparatus marker. This 
particular antibody is harvested from a rabbit, and selectively binds giantin, a protein 
found in the Golgi’s membrane. Primary antibodies such as this are specific to a protein 
of interest such as giantin, but not always fluorescently conjugated. To visualize the 
antibodies with a microscope, a secondary antibody is used that binds to the primary 
antibody. The secondary antibody is conjugated to a fluorescent molecule such as 
Dylight™ to allow visualization. While primary antibodies bind to antigenic epitopes 
present on a protein of interest, secondary antibodies bind to the primary antibodies. An 
example of this kind of antibody is DyLight™ 550-conjugated goat anti-rabbit IgG. This 
antibody was harvested from a goat, and binds specifically to rabbit IgG. Overall, the 
resulting sequence is a cell labeled with a rabbit IgG specific to giantin, which is 
subsequently recognized by a goat anti-rabbit antibody conjugated to  DyLight™ 550  
(Figure 1.8). The secondary antibody binds to the primary antibody, allowing for a 
fluorescent signal to be produced under the microscope when excited.  
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Figure 1.7. General Structure of an Immunoglobulin G (IgG) 32. IgGs consist of two 
heavy chains and two light chains in a Y formation. The central portion of the Y shape is 
a highly conserved region call the Fc region (Top). The two arms of the Y (Bottom) 
contain the Fab region, which is highly variable so as to only bind to specific epitopes.  
 
Figure 1.8. Sequential Antibody Binding Scheme used in Immunocytochemistry (ICC). 
Many primary antibodies (here, rabbit anti-giantin) do not have fluorescent tags to make 
them visible in fluorescence microscopy. To be able to visualize these antibodies,  a 
secondary antibody (e.g. goat anti-rabbit)  is used that specifically recognizes the primary 
antibody, and is chemically conjugated to a fluorescent tag (e.g. DyLight™ 550 needed 
for visualization). 
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1.4 Mammalian Cell Culture  
 A key component of cell studies is the ability to grow consistent and reproducible 
cell lines within the laboratory. This requires a careful monitoring of cellular 
environments and aseptic technique to prevent contamination. To this end, all solutions 
and materials used in living cell work must be sterilized and kept in a dedicated cell 
culture hood. Standard sterile technique protocols were practiced and cells were carefully 
monitored for growth rate, morphology and any potential contamination. 
Over the course of experimentation, HeLa (Human cervical cancer) and N2a 
(mouse neuroblastoma) cells were grown and split once every 2-3 days to maintain a 
cellular environment suitable for exponential growth. It is important that cells do not 
become confluent in order to maintain desired functionalities. N2a cells were split 
approximately 1:5 every 2-3 days to maintain exponential growth conditions, while HeLa 
grew slightly faster, and were split every other day. The cells were split when they 
reached about 80% confluency. Above this density normal cellular function can be lost 
from outside pressures. That is, cells that survive thrive in harsh conditions, and no 
longer represent cellular traits of the cell line selected.  
 
1.5 Microscopy 
Understanding microscope capabilities and limitations is fundamental to drawing 
accurate conclusions from cellular trafficking studies. Imaging of cells was performed 
using an inverted fluorescence microscope from Zeiss with an adapter for a camera. This 
basic setup views the sample from below, allowing for visualization of samples in media 
that could damage the objective in an upright scope. An upright scope views samples 
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from above, making it better for samples such as conventional glass slides when media is 
unnecessary. Depending on sample types, either an upright or inverted scopes is preferred 
for more defined images.  
Filter cubes must be fitted into the fluorescence microscope to select proper 
wavelengths necessary to view the fluorophore used in the experiment.  Many 
fluorophores used as cellular labels have a very distinct excitation and emission 
wavelengths. To excite specific fluorophores, an excitation source with a broad spectrum 
of light between 280-800 nm is used 33. This light is directed into the microscope to the 
filter cube and passed through an excitation filter so that only wavelengths that excite the 
fluorophore reach the sample. Similarly, light emitted from the sample can be selected for 
specific emission wavelengths. The combination allows for a specific fluorophore to be 
viewed by using each specific filter cube.  
Each filter cube consists of three parts: an excitation filter, an emission filter and a 
dichromatic mirror 34(Figure 1.9). Excitation filters allow a specific, narrow range of 
wavelengths to pass through. The selected wavelengths of light then hit a dichroic mirror 
that reflects the desired wavelength range towards the sample; all other wavelengths of 
light do not pass through the filter and are therefore not directed to the sample. The light 
then excites the fluorophore in the sample, which causes fluorescence and emission of 
light that is typically red-shifted from the excitation light. While fluorescence is emitted 
in all directions, some of the light emitted passes down from the specimen through the 
dichroic mirror and through an emission filter. The emission filter only allows light in the 
wavelengths emitted from the fluorophore of interest to pass through and ultimately reach 
the oculars or the camera.  All other wavelengths of light cannot pass through. 
19 
 
Figure 1.9. Light Path through a Filter Cube in an Inverted Fluorescence Microscope 34. 
To obtain a clear image of light emitted from a specific fluorophore in a sample, it is 
essential to block other fluorophores form appearing in the image. To achieve this, a filter 
cube is used to screen the light source (Pictured above as orange) and allows a narrow 
range of wavelengths (Pictured as blue) to hit the specimen. Once excited, the 
fluorophore in the sample emits specific wavelengths of light (Pictured as green) that can 
pass through an emission filter. The emission filter also blocks any undesired 
wavelengths of light (room light, other fluorophores, etc) from reaching the detector.  
 
 
 
Different filter cubes can be used to focus on specific fluorescence sources as 
long as there is little overlap between the excitation and emission wavelengths. Many 
fluorophores can only be excited by a small range of wavelengths, while emitting in a 
small range of wavelengths as well. Fluorophores that significantly overlap in either of 
these cases cannot be used in the same experiment or bleedover (i.e. signals from other 
fluorophores in the sample) can cause erroneous signals. QDs are a strong tool for 
fluorescence image analysis due to the ability to be excited by a wide range of 
wavelengths, with a very narrow band of emitted wavelengths. This makes QDs very 
attractive for co-localization studies where multiple fluorophores need to be visualized at 
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the same time. 
Co-localization analysis is used to determine if the signal collected from two 
different fluorophores originated at the same location in the sample. There are many 
different techniques to calculate the degree of overlap between two signals 35. The 
technique used must be carefully selected depending on the nature of the sample and the 
specific data desired. For this experiment, we evaluated the degree of overlap between 
the signals from two fluorophores using what is called the Manders’ coefficient 4. This 
calculation can be seen here: 
𝑀! = 𝑅!,!"#"!𝑅!  
 Ri is the occurrence of a specific fluorescence signal, while Ri,coloc is the 
occurrence of that signal overlapped with a second signal of interest. Mi is a value 
between 1 (indicating completely positive correlation) and 0 (indicating completely 
exclusive correlation) 35. 
The Manders’ coefficient allows for a quantitative measure of the degree of 
overlap between two fluorophores when the two images are overlaid using an image 
processing software (e.g. ImageJ). The Manders’ coefficient was chosen for co-
localization analysis in this work for the ability to emphasize the importance of one signal 
over another. In this case, QDs are the signal of focus. That is, the degree the QD signal 
overlaps with the organelle marker signal (e.g. Golgi apparatus, lysosomes) is of greater 
interest than the degree the organelle signal overlaps with the QD signal. In short, this 
analysis does not include the potentially large signal from organelles that do not overlap 
with the QD signal (e.g. some lysosomes that do not contain QDs). It only returns 
information about the QD signal and its degree of overlap from the organelle marker 
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signal. 
 This work hopes to achieve a high quality synthesis of QDs for further 
modification. The QDs are then functionalized to act as nanocarriers for DNA delivery to 
a targeted area of the cell (Nucleus). In this way the QDs could act as a therapeutic DNA 
delivery vehicle for targeted gene therapy methods.  
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CHAPTER 2: EXPERIMENTAL 
 
2.1 Chemical List 
All materials were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise specified. Acetone (wash grade), cadmium oxide (Cat. No. 202894), agarose 
(MidSci, Cat. No. BE-A125), 3-dimethlamino-1-propylamine (DMAPA) (Cat. No. 
D158003), 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride  
(DMTMM) (Cat. No. 749613), hexanes (EMD Millipore, Cat No. 110-54-3), N-(2-
Aminoethyl)maleimide trifluoroacetate salt (Cat No. 56951), 3-(N-
morpholino)propanesulfonic acid (MOPS) (Fisher Bioreagents Cat. No. BP308-500),  
octadecene (Acros, Cat. No. 112-88-9), oleic acid (Cat. No. 364525), oleylamine (Acros, 
Cat. No. 112-90-3), paraformaldehyde (PFA) (Cat. No. 158127), phosphate buffer saline 
(PBS) (Thermo Scientific, Cat. No. SH30028.02), polyethylene glycol (PEG) derivatives 
(Creative PEGworks, 2HN-(PEG)2000-CH3 [“mPEG”] Cat. No. PLS-269, 2HN-(PEG)2000-
COO-  [“cPEG”] Cat. No. PHB-930 (cPEG)), commercially available under the name 
poly(maleic anhydride-alt-1-tetradecene), 3-(dimethylamino)-1-propylamine derivative ( 
from here on referred to as PMAL-d) (Cat. No. 90771), selenium powder (Cat. No. 
229865), sulfur powder (Cat. No. 84683), tetrahydrofuran (THF) (Cat. No. 401757), 
trioctylphosphine oxide (TOPO) (Strem Chemicals, Cat. No. 78-50-2), Triton X-100 
(Astoria-Pacific, Cat. No. 90-0770-04), wheat germ agglutinin (WGA) (Cat. No. 61767), 
zinc oxide (Cat. No. 96479). 
 For mammalian cell culture work the following biological reagents were 
purchased: pGFP-EEA1 (plasmid DNA encoding enhanced green fluorescent protein 
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fused to EEA1, AddGene Cat. No. 42307), Dulbecco’s-Modified Eagle’s medium (D-
MEM) (Thermo Scientific, Cat. No. SH30022.01), Opti-MEM reduced serum medium 
(Life Technologies, Cat. No. 51985-034), rabbit anti-giantin antibody (Golgi Apparatus 
Marker, Abcam, Cat. no. ab24586),  Dylight™ goat anti-rabbit IgG 550 conjugate 
(Thermo Scientific, Cat. No. 84541), LysoTracker (Molecular Probes, Cat. No. L7526), 
fetal bovine serum (Hyclone, Cat. No. SH30396.02) antibiodic/antimicotic solution 100X 
(Penicillin G, Streptomycin, and Amphotericin B) (Hyclone, Cat. No. SV30079.01), 
trypsin (Hyclone, Cat. No.AV30031.01), trypan blue (Hyclone, Cat. No. AV30084.01) 
and SYBR® Green (Life Technologies, Cat. No. S-7563). N2a (mouse neuroblastoma) 
cells and HeLa (human cervical cancer) cells were a kind gift from Dr. Tania Q. Vu at 
Oregon Health and Science University and Dr Paul Durham at Missouri State University 
respectively. 
 
2.2 QD CdSe Core Synthesis 
The Se precursor for CdSe QD cores was synthesized by adding 33 mg selenium 
powder to 5 mL octadecene in a sealed 50 mL round bottom flask. This mix was purged 
with a vacuum for 30 minutes and filled with nitrogen gas to avoid oxidation of 
trioctylphosphine in future synthesis steps. The mix was purged for ~20 min and then 
heated to 150 °C. The temperature was controlled with a thermocouple and proportional-
integral-derivative (PID) controller to keep the temperature within +/- 2°C of the target 
temperature. The thermocouple and controller were calibrated with 
oleylamine/octadecene from 0 to 320 °C and found to be stable for at least 1 hour. After 
stabilizing the temperature for at least 10 min, 0.4 ml of trioctylphosphine was carefully 
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injected to prevent exposure to air. The black selenium powder fully dissolved as it 
reacted to form selenium trioctylphosphine, the Se precursor to the CdSe QD formation. 
The temperature was maintained at 150 °C until no visible selenium was left in the 
solution (Approximately 15 minutes). 
The Cd precursor was synthesized by adding 19.5 mg of cadmium oxide to a 100 
mL, 3 neck, RBF along with 25 mL of octadecene and 25 mL oleylamine. A mixture of 
octadecene and oleylamine was used as the solvent. This mixture was chosen because it 
was found to stabilize CdSe core formation and produce more consistent core quality 
than octadecene alone. Once the mixture was sealed, it was purged with argon gas. This 
setup allows for a condenser to be added, which minimized solvent loss due to 
evaporation while maintaining an inert atmosphere. The middle neck of the RBF was 
used to vent, while the other two necks were used for reagent injection and introduction 
of a thermocouple (see Figure 2.1). The heat was raised and stabilized to 150 °C and 0.9 
ml of Oleic acid was injected to dissolve the cadmium oxide. The reddish powder fully 
dissolved to create a clear liquid, indicating the solution was ready for injection of the Se 
precursor to induce nanoparticle nucleation.  
Once the Cd precursor solution was prepared in the reaction chamber, the solution 
was heated to 300 °C and stabilized for the duration of the reaction. Many trials were 
performed at temperatures as low as 250 °C and as high as 320 °C, but these temperatures 
yielded poorer quality cores. After the Cd precursor solution was stabilized at 300 °C, 1.5 
ml of selenium-trioctylphosphine precursor was injected. The temperature initially 
dropped after injection, but the PID temperature controller stabilized the solution back to 
300 °C within roughly 15-30 seconds. Samples of the product can be collected at regular 
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time intervals to ensure steady core growth.  Using these reaction conditions, CdSe QD 
products were obtained with a fluorescence emission λmax of 650 nm and, a very narrow 
full-width at half max (FWHM) of 25-30 nm, similar to that of commercially available 
QDs. CdSe cores were purified via precipitation with excess acetone (75 mL acetone for 
25 mL QDs). This solution was then centrifuged at 12,000 x g  for 1 hour. The precipitate 
was dissolved in hexane for longer storage and preparation for ZnS coatings. This wash 
process was repeated three times to ensure purification. 
 
 
Figure 2.1. Reaction Setup for CdSe QD Synthesis. A three-neck RBF was used for ease 
of reagent injection, while simultaneously being able to monitor the reaction with a PID 
temperature controller and maintain an inert atmosphere. A second valve at the top of the 
condenser allowed for the reaction to be sealed or subjected to vacuum, as needed. This 
setup could also be adjusted from a 100 mL RBF up to 500 mL. However, it was found 
that an increase in reaction volume increased the size dispersity of the QD products. 
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2.3 Passivation of CdSe QDs with a ZnS Shell 
A few different methods were attempted before settling on the most consistent 
ZnS shell coating procedure. The first attempts used a pyrophoric method and included 
the use of diethyl zinc and trimethylsiylsulfide (TMS) under an inert atmosphere. 
Without a glove box, this procedure may become very hazardous since the diethyl zinc 
reacts explosively with water and can easily catch fire upon contact with air. 
Additionally, TMS is a potent toxin with a very unpleasant smell. Mixed results were 
obtained with this reaction. Some trials achieved the growth desired, while other trials 
showed little-to-no growth (i.e. did not demonstrate the expected photoprotective effects 
of passivation when viewed on a fluorescence microscope). While this procedure has 
been previously published 36, and has worked for others, without the use of a gloves box, 
it became impractical to continue this technique for our purposes.  
The most consistent method, and the one used most often in these experiments, 
was the Successive Ionic Layer Adsorption and Reaction (SILAR) method, suggested by 
Dr. Collin Heyes at the University of Arkansas. This method allows for a controlled 
addition of each layer of zinc and sulfur to the core. The Zn or S precursor solutions were 
prepared to coat 200 µL of CdSe QDs with a concentration of about 4 µM. The Zn 
precursor was a stock solution of zinc oxide (3.2 mg) dissolved in 18.2 mL octadecene 
and 1.8 mL oleic acid; the sulfur precursor solution was 102 mg elemental sulfur 
dissolved in 20 mL octadecene. Both precursor solutions were heated to 200 °C to 
dissolve fully. The zinc precursor was cooled to 80 °C while the sulfur precursor was 
allowed to return to room temperature. The injection volumes necessary for each 
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precursor injection were calculated using the lattice constant for ZnS and the diameter of 
CdSe cores. 
The extinction coefficient and diameter of CdSe cores was determined using the 
first excitonic peak, as described in the introduction. The extinction coefficient and 
diameter are needed to calculate the concentrations of the CdSe solution. Once the 
current nanocrystals diameter is known, the expected diameter, with the addition of one 
monolayer (ML) of ZnS, can be calculated using the lattice constant for Wurtzite (e.g. 
ZnS, 0.626 nm). The difference in volume between a CdSe core and a core with single 
ML of ZnS, was calculated using the equation VML=3/4π(RTotal-Rcore)3 . The moles of 
precursor needed for each ML was calculated using the bulk density for ZnS (42,100 
mol/m3). Each injection was calculated this way, increasing the diameter of the core as 
needed to account for the additional MLs. 
CdSe QD cores were brought to 150 °C and stabilized, and the calculated volume 
of zinc or sulfur precursor was injected to allow one full coating of the nanoparticle. The 
reaction was allowed to proceed for 15 min before the next injection. A total of 4 zinc 
layers and 4 sulfur layers were added in succession. After the last injection the 
temperature was allowed to cool to room temperature. The CdSe/ZnS nanocrystals were 
then washed using the same method for CdSe cores and centrifuged at 12,000 x g for 1 
hour to remove any unreacted precursors. These cores were stored in hexanes to prepare 
for water solubility.  
 The SILAR method requires more time than the pyrophoric method mentioned 
above, but reduces the chance of ZnS nucleation and offers more synthetic control than 
bulk shell synthesis. A 5-10 nm growth is indicative of successful shell passivation.  Type 
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1 core/shell systems have a characteristic 10 nm shift in fluorescence λmax upon 
successful addition, which has been attributed to the “leaking” of electrons into the shell 
bands 1. A shift in fluorescence λmax, as well as resistance to photobleaching, are good 
indications of successful core passivation. These CdSe/ZnS QDs were visualized using a 
fluorescence microscope for up to 60 min with little-to-no noticeable photobleaching. 
 
2.4 Imparting Water Solubility to CdSe/ZnS QDs 
 For QDs to be biologically relevant for gene therapy applications, they must be 
solubilized in water. There are many ways to accomplish this (previously described in 
Chapter 1). The use of an amphiphilic polymer was the primary focus of this work. 
Attempts were made to synthesize an amphiphilic polymer in-house with mixed results.  
It was quicker and cheaper to purchase an ideal polymer that was shown to be suitable in 
previous work 37. Polymer synthesis was quick, but characterization and optimization of 
the degree of functionalization took longer than anticipated. The commercial polymer 
selected for water solubilization was purchased under the name Poly(maleic anhydride-
alt-1-tetradecene), 3-(dimethylamino)-1-propylamine derivative ( from here on reffered 
to as PMAL-d, Figure 2.2). 
First attempts at water solubilization started with a mixture of CdSe/ZnS QDs 
(capped with TOPO), in octadecene, with a large excess of PMAL-d dissolved in water. 
The mixture was sonicated for one hour, with occasional vortexing. This method resulted 
in a portion of QDs stable in water, but a much larger portion was present as an insoluble 
QD precipitate. This precipitate made concentration calculations impossible for these 
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trials. A more efficient water solubilization method was needed to be able to account for 
the final concentrations of the QDs in water. 
 
 
Figure 2.2. Chemical Structure of PMAL-d 38. PMAL-d was used for the water 
solubilization of CdSe/ZnS QDs. Its long 12-carbon chain allows interaction with TOPO 
ligands bound to the QD surface. This polymer also has tertiary amine functionalization, 
which is protonatable at physiological pH, to impart some positive charge to the QD 
surface. Finally, carboxyl groups of this polymer can be used as “chemical handles” for 
further bioconjugation. 
  
A paper published in Nature Protocols 17 offered an alternative method, which 
called for suspending the QDs in THF before adding PMAL-d. Excess THF was slowly 
evaporated off, using a rotary evaporator, during the mixing procedure, allowing for QDs 
to be suspended within the water more efficiently. In theory, the slower evaporation 
(typically 3-4 hours) allowed more time for the QDs to be wrapped in the polymer and 
increased overall yield of water-soluble QDs. As the organic layer evaporated, it became 
less and less energetically favorable for the QDs to stay within the shrinking organic 
layer. While this method showed promise, it was not without limitations: CdSe/ZnS QDs 
quenched if exposed to THF for too long. The exact length of time before quenching 
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varied between trials. We speculate this variability may be due to the individual quality 
of the QD products used (i.e. the existence of trap states on the surface of the QDs, or 
defects in ZnS coating). As the QD quality increased, the time before quenching was 
extended.   
 Before solubilization, QDs were precipitated from hexanes and washed. This was 
achieved by adding 30 mL acetone to the QDs (1mL of 4µM) and centrifuging at 12,000 
x g for 15 minutes. If red fluorescence (from unprecipitated QDs) was detected in the 
acetone, the addition of acetone and spin would be repeated. The precipitated QDs were 
then dissolved in 20 mL THF. To ensure the QDs were fully dissolved, the solution was 
sonicated for ~15 min. Once the QDs were fully dissolved, 30 mL of ~1mg/mL PMAL-d 
in DI water was added to the QDs in a 100 mL RBF, and the solution was rotovaped with 
a dry ice/acetone trap. Once the majority of the THF evaporated (roughly 80%) the 
solution appeared turbid in nature; at this point 50 mL of DI water was added. The rest of 
the THF and most of the DI water was evaporated slowly over the course of ~3 hours, or 
until the solution reached the desired concentration. The water-soluble QDs were kept at 
a concentration of at least 500 nM to avoid long term storage issues. 
 In many cases, dialysis was needed to remove excess polymer from the water-
soluble QDs, indicated by solution turbidity. The turbidity may have been due to the 
formation of micelles by excess polymer. To purify the solution, it was dialyzed using a 
membrane with a MWCO of 20,000 kDa against 0.1M borate buffer, pH 8.5. Successful 
purification was indicated by the lack of turbidity post-dialysis. The solution was then 
concentrated using a vacufuge. 
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The coating with amphiphilic polymer to impart water solubility was performed 
in these experiments for the simple nature of the reaction compared to strategies 
incorporating ligand exchange. The experimental setup was cheaper, and more 
importantly, easier to repeat due to the less intense experimental design.  
 
2.5 Surface Modification of Water-Soluble CdSe/ZnS QDs 
Once the QDs were stable in water, they must be able to interact with DNA. The 
plasmid pGFP-EEA1 was purchased from Addgene and encodes for a green fluorescent 
protein (GFP) early endosomal marker within mammalian cells. This marker is an N-
terminal fusion protein of GFP to EEA1. The GFP fusion allows for the gene to act as a 
reporter gene to indicate successful gene transfer. This plasmid was used because circular 
pDNA is more resistant to enzymatic degradation than linear DNA. The bacterium 
Escherichia coli (E. coli), containing pGFP-EEA1was grown on lysogeny broth (LB) 
agar plates, containing 50 µg/mL kanamycin for plasmid maintenance, at 37°C overnight. 
This LB medium was composed of: 
Tryptone – 10g 
Yeast Extract – 5g 
NaCl – 10g 
H2O (Distilled) – to bring final volume to 1000 mL 
A single well isolated colony was transferred to a 5 mL liquid LB and grown at 
37°C and 200 rpm for approximately 24 hours. After outgrowth, the pGFP-EEA1 
plasmid was purified using the Gene Jet miniprep kit according to the manufacturers 
protocol (Thermo Scientific). The concentrations and purification of each collected 
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plasmid sample was calculated measuring the absorption at 260 nm and 280 nm by 
spectrophotometry. The recovered plasmid was stored at -20°C in TBE buffer until 
needed. The first sample of replicated and purified plasmid was digested with XbaI and a 
combination of Xhol/EcoRI and separated by electrophoresis with a 0.4% agarose gel to 
verify plasmid identity. 
The first QD conjugation consisted of two simultaneous reactions. In the first 
reaction, PMAL-d on the surface of the QDs was functionalized with tertiary amines to 
increase the surface charge. By imparting a positive charge on the QD surface, the QDs 
can electrostatically interact with polyanionic pDNA. While the amphiphilic polymer, 
PMAL-d, has some positive character (due to tertiary amines that are protonatable at 
physiological pH), an increase in the overall surface charge was found to be necessary to 
allow more pDNA to bind to the QD surface. To this end, PMAL-d on the surface of the 
QD, was functionalized with more tertiary amines in the form of 3-(dimethylamino)-1-
propylamine (DMAPA).To accomplish this, carboxylate groups on the QD surface were 
activated with 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride 
(DMTMM) using a stoichiometry of 10,000 DMTMM to 1 QD (See Figure 2.3) in 0.1M 
borate buffer. DMTMM acts as an intermediate to react the carboxylic acid 
functionalities on the polymer coating the QD with the secondary amine groups on the 
end of cPEG and mPEG.After reaction for 15 minutes, excess DMTMM and byproducts 
were removed from the solution by dialysis with a 20,000 MWCO membrane. After 
collecting the solution from dialysis, DMAPA was added and allowed to react. 
Simultaneously during the above reaction, two polyethylene glycol (PEG) derivatives, 
“mPEG” and “cPEG” (see chemical list for structure) were added, both a 2,000 x molar 
33 
excess to QDs. PEG derivatives decrease the nonspecific binding of the QD and 
functionalize the QDs with both methyl and carboxylate terminal groups. The 
stoichiometric ratio of DMTMM:QD was varied in each trial (ranging from 10,000 to 
500,000) to optimize the amount of tertiary amine reacted to increase the positive surface 
charge of the QD enough to bind pDNA. Unreacted DMAPA and PEGs were removed by 
dialysis overnight. 
 
 
Figure 2.3. Mechanism of Activation of Carboxyl Groups by DMTMM 12. DMTMM was 
used to activate the carboxylate groups of PMAL-d on the QD surface. Through this 
activation, other functionalization could be imparted to the surface through the reaction 
with a secondary amine.  
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Electrophoretic gels were used to evaluate ability of the QD-PEG/tert-amine 
conjugate to electrostatically bind negatively charged pDNA. The QD-PEG conjugates 
were evaluated on 0.4% agarose gels with SYBR® Green (a fluorescent DNA dye). The 
QD-PEG/tert-amine conjugates were incubated with ~0.1 µg pDNA at room temperature, 
for 30 min before loaded into the gel.  The amount of QDs added to each trial was 
adjusted to evaluate electrostatic interaction of the DNA with QD-PEG/tert-amine 
Conjugates. The samples were electrophoresed 1 hour at 60 volts.  
The surface charge of QD-PEG/tert-amine was evaluated using Zeta-potential 
measurements on a DLS instrument (Brookhaven Nicomp Model 380). A small sample 
of QD-PEG/tert-amine was diluted to 15 nM (in DI water) to evaluate the surface charge. 
The smallest portion possible was used since the technique is destructive to the QD-
PEG/tert-amine sample. 
 
2.6 Bioconjugation of QDs with Wheat Germ Agglutinin  
Functionalized QDs may be able to bind pDNA, but need a trafficking group to 
guide the contents once within the cell. In an effort to target the pDNA payload to the 
cellular nucleus, QDs were bioconjugated to wheat germ agglutinin (WGA). WGA is a 
naturally occurring lectin that has been shown to bind to the nuclear envelope of the cell 
39. By attaching WGA to the QD-PEG/tert-amine conjugate, we hope to exploit natural 
endocytic pathways (Discussed in Chapter 1), to reach the nucleus of the cell. To achieve 
this goal, a two-step reaction scheme was developed to conjugate WGA to QD-PEG/tert-
amine conjugate. 
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In the first reaction, the QD-PEG/tert-amine conjugate was reacted with 
maleimide to form a reactive intermediate that could bind to WGA. Terminal carboxylate 
groups from PMAL-d and cPEG on the QD surface were activated with DMTMM. A 
10,000 x mole excess of DMTMM was reacted with QD conjugates for 5 min, then the 
solution was dialyzed over 10 min. After dialysis, N-(2-Aminoethyl)maleimide 
trifluoroacetate salt was added in a 100:1 mole excess (Figure 2.4, I and II). This 
conjugation creates a maleimide intermediate that can react with WGA. The maleimide 
derivative reacts with free sulfhydryl groups (e.g. in the form of cysteine side chains in a 
protein) at pH 7. Maleimides can also react with amines, but at pH 7.0 - 8.0 the reaction 
with free sulfhydryl groups is 1000x more favorable than with amines 40. This reaction 
was performed in MOPS buffer at pH 7.4 to encourage reaction with sulfhydryl groups. 
Once the maleimide reaction was completed, WGA (containing 4 free sulfhydryl 
groups [cysteine side chains] in its native, folded state) was added to the reaction (Figure 
2.4, III, IV). A 2x molar excess of WGA was added in an attempt to prevent aggregation 
of multivalent products. The solution was allowed to react for 2 hours, and then a 
saturated cysteine solution was added to quench any remaining maleimide. The excess 
WGA and cysteine was removed using a 50,000 MWCO centrifugal filter. 
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Figure 2.4. Reaction of Free Sulfhydryl with Maleimide Derivatives 40. , N-(2-
aminoethyl)maleimide was reacted with QD conjugates using DMTMM activation (I and 
II). The maleimide intermediate (product depicted in II) can undergo hydrolysis if left 
unreacted over longer periods of time. Therefore, Step III was carried out immediately 
after step II.  
  
2.7 Cellular Interactions with WGA-QD Conjugates 
Model cell lines were used to visualize the intracellular trafficking pathway of the 
WGA-QD conjugate. HeLa (Human Cervical Cancer) and N2a (Mouse Neuroblastoma, 
ATCC Cat #HB-12317) cells were split every 2-3 days at a 1:10 ratio. Cells were grown 
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in media consisting of 50% Dulbecco’s Modified Eagle’s Medium (DMEM) and 50% 
Opti-MEM supplemented with 10% fetal bovine serum (FBS) as well as 1X antibiotic 
and antimicotic solution (Penicillin G, Streptomycin, and Amphotericin B). N2a cells 
were plated in a 6 well plate containing a 25 mm2 glass cover slip at a density of 50,000 
cells per well and incubated for 1 day at 37 °C in a 5 % CO2 atmosphere. Experiments to 
visualize live cell internalization of QDs, as well as visualization of cells fixed after 
timed QD-WGA conjugate internalization, were performed. 
Two methods of visualization were used for living and fixed samples of cells. Ten 
µL of 40 nM QD-WGA conjugates were added to each well of cells. For live cell images, 
lysotracker (to visualize lysosomes) was added 20 min before the addition of the QD-
WGA conjugate. The QD-WGA conjugate solution was added after placing the 25 mm2 
coverslip in a magnetic imaging chamber with cellular media so that the full 
internalization process could be observed in living N2a cells. Cells that were fixed were 
incubated with QD-WGA conjugates for 1 hour, 2 hours or 4 before fixation with 4% 
paraformaldehyde for 15 minutes. The fixed cells were stored in borate buffer (pH ~8.5) 
at 4°C. The following day the cells were permeabilized with 0.5% Trition X-100. Cells 
were blocked with 10% BSA for 1 hour, then treated with rabbit anti-giantin (Golgi 
marker) for 1 hour at a dilution of 1-1000 in 10% BSA (in PBS). After 1 hour the cells 
were washed 3 times with PBS buffer for 15 minutes. Afterward the cells were blocked 
again with 10% BSA for 1 hour before being treated with a secondary antibody DyLight 
550™ goat anti-rabbit for 1 hour. The washing steps were repeated and the cells were 
stored in borate buffer pH 8.5. The coverslips were fitted into a magnetic imaging 
chamber for visualization under the fluorescence microscope. 
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A Zeiss Axio Observer microscope with a CCD camera (Zeiss axiocam Mrm) was 
used to visualize the cells. The microscope was equipped with filter sets: Rhodamine 
(ex545/em605), FITC (ex470/em525), and DAPI/Hoeschst (ex375/em460) and QD 
(ex460/em500LP) (Figure 2.5). Filter cubes were selected to visualize each fluorophore 
individually from the QD in each trial. The QD filter could not be used for visualization 
of QDs in the lysotracker experiment due to the co-excitation of lysotracker, leading to a 
possible false signal since the emission filter allows >500 nm to pass. Special attention 
was necessary to ensure the fluorescence signal from QD-WGA conjugates did not 
overlap with fluorescence signal from Lysotracker®. QD-WGA conjugates exhibited 
fluorescence emission at ~630 nm with a FWHM of roughly 30 nm. Specific excitation 
and emission filters were used to ensure these two signals did not overlap (Figure 2.6). 
For QD visualization a filter cube was assembled with a Rhodamine excitation filter (540 
nm +/- 20 nm) and a Rhodamine red emission filter (610 nm +/- 40 nm). This allowed 
exclusive excitation of QDs and not the Lysotracker®. The use of a standard FITC cube 
(ex470/em525) was used to excite lysotracker. The final images were edited using 
ImageJ before being subjected to colocalization analysis using the Manders’ coefficient 
plug-in. 
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Figure 2.5. Filter Cube Excitation and Emission Cutoffs. Four different filter cubes were 
used for the fluorophores utilized in this work (Hoechst, QDs, Lysotracker, Dylight-550). 
FITC (A) was used to visualize lysotracker dye due to the lower emission filter (525 +/- 
50 nm). QD filter (B) was used to visualize QDs for the long pass filter that allowed any 
emission over 500 to pass. Rhodamine (C) was used to visualize the QDs in the 
lysotracker trial to prevent excitation of lysotracker dye. Finally DAPI (D) was used to 
visualize Hoechst dye. 
 
 
Figure 2.6. Excitation and Emission Spectra for Rhodamine Filter Cube Compared with 
Fluorescence Spectrum of Lysotracker and QDs.41  To achieve individual visualization of 
lysotracker, Hoechst, DyLight™-550 and QDs, different filter cubes were utilized. A 
filter cube for the QDs was assembled with a rhodamine excitation filter to avoid 
excitation of lysotracker and a rhodamine emission filter at ~610-630 nm to capture the 
QDs. 
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CHAPTER 3: RESULTS AND CONCLUSIONS 
 
3.1 CdSe QD Core Synthesis 
The QD CdSe core synthesis produced core sizes ranging from 2-7 nm (calculated 
using absorption spectroscopy) depending on the reaction duration. Samples were taken 
in 2 min intervals to determine ideal reaction time to synthesize cores with an emission 
peak of ~655 nm. Emission at 655 nm does not overlap with other fluorescent dyes used 
in these microscopy experiments, making this size of QD ideal for co-localization 
analysis. Above 655 nm (~6 nm diameter) QDs have been shown to lose spherical 
morphology, becoming more rod-like1. Because calculations used to coat the cores with 
ZnS are based on QDs with spherical morphologies, larger QDs with rod-like 
morphologies were avoided. CdSe cores quickly grow to red-emitting QDs over the 
course of only a few minutes (Figure 3.1, 3.2). While core growth was consistent, some 
delay in core growth was observed over time as the amount of Cd and Se precursor 
diminished. This could be adjusted by increasing temperature, or precursor solution 
concentrations, to increase or decrease QD diameter, making each synthesis tunable to 
obtain the desired size. Early trials were successful, but as the reaction conditions and 
setup was optimized, QD products demonstrated an increase in fluorescence intensity. 
While the first successful QD core products had a relative fluorescence unit (RFU) value 
of only ~600 RFU, more recent trials have obtained values of ~27,000 RFU. While the 
degree of fluorescence intensity is relative to each synthesis, visual inspection confirmed 
the significant increase fluorescent intensity with optimized conditions. The quality of 
each synthesis was further improved with an adjustment of solvent from pure octadecene 
41 
to a 50:50 mixture of octadecene:oleylamine. This mix was found to act as a better 
coordinating ligand to improve the size monodispersity of each synthesis. The mixture 
also allowed for higher temperatures to be stably maintained, raising the maximum stable 
temperature from ~280°C to over 300°C. This reduced the amount of time necessary to 
obtain quality red-emitting QDs from ~45 min to ~20 min. The solvent switch resulted in 
much more consistent growth rates of QD cores, and a higher quality CdSe core when 
viewed under the fluorescence microscope. 
 
Figure 3.1. Core CdSe Growth Monitored by Fluorescence Spectroscopy. Samples were 
collected from the reaction mixture every minute to observe core growth rates (A). It was 
found that reaction for 15 minutes at a temperature of 300°C obtained CdSe QD products 
with a fluorescence emission of ~630 nm, with a very narrow peak width of ~30 nm (B). 
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Figure 3.2. Visual Observation of CdSe QD Core Growth. Samples were taken 
immediately after injection and every minute after to visualize QD growth over time. 
 
 
 
Once CdSe cores were synthesized and washed to remove excess precursor, 
products were experimentally stored in various solvents for 1 week to investigate the 
effects of solvent on QD fluorescence stability. It was found that hexane was the best 
solvent for longer storage to reduce quenching. Therefore, CdSe QD cores were stored in 
hexanes and sealed under nitrogen in a -20°C freezer until subsequent addition of ZnS 
coating. Storage concentration below 500 nM resulted in increased aggregation 
(empirical observation). CdSe cores concentrations were calculated to be between 1-4 
µM after initial washing steps for most trials. 
These highly fluorescent CdSe cores were visualized by a fluorescence 
microscope and demonstrated distinctive blinking pattern associated with single CdSe 
QDs. However, visualization with prolonged exposure to UV light demonstrated a blue-
shift in fluorescence (from red-orange to yellow, then green) (Figure 3.3). This change in 
color is speculated to be due to the decrease in QD size as a result of degradation. 
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Figure 3.3. CdSe Cores after Prolonged Exposure to UV Light Observed via Fluoresence 
Microscopy. Orange-red Emitting QDs slowly degrade to emit yellow and green 
fluorescence after exposure to UV light (~10min). This is a sign of oxidation of the core. 
The degradation can be controlled with a protective coating on the outside of the cores, 
both to prevent degradation and correct any imperfections that cause trap states. 
 
 
 
 The narrow fluorescence emission peak width, indicating monodispersity of QDs, 
ranged between 26-30 nm at FWHM for a typical synthesis (Figure 3.1). This narrow 
range indicates that QDs were very monodisperse in size when compared to the 
theoretical limit for CdSe of 25 nm42.  QDs that were more monodisperse in size 
generated core/shell QDs with a more uniform coating (vs. polydisperse CdSe cores) 
when coated using the SILAR method.  
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3.2 Passivation of CdSe QDs with ZnS Shells 
 Addition of a ZnS shell to the outer layer of CdSe cores protects cores from 
oxidation and degradation. This allows for increased photostability and potentially 
reduces the toxicity of QDs in biological systems (due to the generation of Cd+2 ions 
during core degradation). Three different methods of ZnS coating were attempted before 
the SILAR method was selected. The first method attempted was a pyrophoric synthesis 
with the use of diethyl zinc, an extremely explosive chemical when in contact with air. 
This method involved injections similar to the SILAR method mentioned in the 
experimental section, but was much more dangerous. Ultimately, this method was 
abandoned due to difficulty keeping the reaction in an inert environment during 
synthesis. The second method (the “sonication method”) involved adding 
zincethylxanthate or zinc stearate in excess and sonicating the mixture at lower 
temperatures (<80°C). This method was much easier and required very little setup, but the 
results of each coating were extremely inconsistent. Many of the CdSe/ZnS products 
obtained through this method aggregated very quickly compared to the SILAR method 
(Figure 3.4).  
 The method that showed the most promise and consistent results was the SILAR 
method. This method showed immediate improvement of CdSe properties when 
compared to sonication and pyrophoric methods in both fluorescence intensity and 
decreased aggregation. More importantly, the SILAR method produced consistent results 
across trials, coating each CdSe core with 3-5 monolayers (MLs) of ZnS. Successful 
coatings were evaluated by fluorescence spectra of the QDs and analysis of emission 
peaks for the characteristic red-shift in λmax of ~5-10 nm. This shift, as well as an increase 
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in fluorescence intensity, is strong indications of successful ZnS coating (Figure 3.5). 
ZnS coating was also confirmed using a fluorescence microscope to visualize QDs over 
the course of ~ 45 minutes with constant UV exposure. QDs visualized this way showed 
no visual loss of fluorescent intensity or change in fluorescence color. 
 
Figure 3.4. Fluorescence Micrographs of CdSe/ZnS QD Products. Aggregation of QDs is 
easily seen in the sonication method (A). The SILAR method (B), produced much fewer 
aggregates and demonstrated rapid blinking indicative of single QDs. 
 
 
  
 
Figure 3.5. Fluorescence Spectrum Characteristics of CdSe vs. CdSe/ZnS QDs. Uncoated 
CdSe QD cores (Red line) had a maximum emission at ~625 nm (A), while after the 
same trial of CdSe was coated with ZnS the emission shifted to ~630 nm (B). The λmax of 
CdSe cores is indicated in A, and λmax of CdSe/ZnS core/shells is indicated in B. The 
characteristic increase in emission wavelength, as well as an increased intensity from 
~110 RFU (red line) to ~410 RFU (black line) is characteristic of successful ZnS shell 
addition. 
 
A B 
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3.3 Imparting Water Solubility to CdSe/ZnS QDs 
 Transferring CdSe/ZnS QDs from organic solvent to water proved to be the single 
most difficult task in this work. Using an amphiphilic polymer to impart water solubility 
to the QDs was successful, but suffered from very inconsistent results between trials. 
Many trials using the amphiphilic polymer resulted in the aggregation of QDs and 
subsequent precipitation as soon as the THF was completely evaporated. The original 
polymer used was ~40% diethylamine-modified poly(acrylate) synthesized in-house. 
However, purification and characterization of this polymer proved laborious and time 
consuming. Therefore, a commercial polymer, PMAL-d, was used for future trials. A 
2,000:1 stoichiometric ratio of polymer:QD was used to ensure excess polymer in 
solution. Trials using minimal amounts of polymer resulted in precipitation of QD 
products during centrifugation (~5,000 x g). The stoichiometric ratio of PMAL-d was 
optimized to ~2,000x molar ratio of CdSe/ZnS QDs for consistent stability in water. 
Exceeding this ratio resulted in a very turbid solution, likely due to micelle formation. 
Decreasing this ratio resulted in decreased stability in water (aggregation and 
precipitation). 
While coating QDs with the amphiphilic polymer coatings consistently stabilized 
QDs into water, there was also a high variance between trials. Many of the QDs 
aggregated very quickly over the course of ~48 hours. Once out of solution, sonication 
(that would stabilize CdSe/ZnS cores in organic solvents) only disrupted the polymer 
coating further, resulting in increased precipitation. The calculated concentration of QDs 
in solution at this point became invalid; therefore, many trials could not be used for 
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conjugation steps after this point. QDs that were successfully stabilized in water were 
visualized on a microscope before use in conjugation trials to ensure consistent long-term 
stability. Many trials were observed over the course of months with little to no decrease 
in stability. However, other trials were stable for only 2-3 days before producing a visible 
precipitate when centrifuged (~5,000 x g). The best trials were observed to be stable for 
over 6 months in 0.1M borate buffer. 
 
3.4 Surface Modification of Water-Soluble CdSe/ZnS QDs 
 Once CdSe/ZnS QDs were stable in water, the amphiphilic polymer was 
functionalized to 1) reduce non-specific interactions with cells, and 2) allow QDs to bind 
DNA. To reduce non-specific binding of cellular proteins, cPEG and mPEG were 
conjugated to PMAL-d. This was shown in previous work to reduce non-specific binding 
of QD nanocarriers in cells43. To condense DNA onto QDs, 3-dimethylamino-1-
propylamine (DMAPA) was reacted with PMAL-d to increase the net positive surface 
charge. This increase in charge was intended to allow an electrostatic interaction between 
QDs and negatively-charged DNA. The amount of positive charge was adjusted by 
increasing the molar amount of DMTMM used to activate carboxyl groups of the 
polymer. The increased positive charge allowed for more DNA to electrostatically 
interact with the surface, causing an increased carrying capacity of the QD for DNA. 
These two reactions were performed sequentially (first PEGylation, and then reaction 
with DMAPA) in preliminary experiments. A positive charge of ~+30 mV (Table 3.1) is 
indicative of successful tertiary amine functionalization. These were compared with 
standard values of unfunctionalized QDs (-10 to -30 mV)44 and can be seen below:  
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Sample	   Zeta	  Potential	  (mV)	  
15	  nM	  Water	  Soluble	  QD-­‐PEG/tert-­‐amine-­‐1	   28.94	  
15	  nM	  Water	  Soluble	  QD-­‐PEG/tert-­‐amine	  QDs-­‐2	   31.60	  
15	  nM	  Water	  Soluble	  QD-­‐PEG/tert-­‐amine	  QDs-­‐3	   29.10	  
15	  nM	  Water	  Soluble	  QD-­‐PEG/tert-­‐amine	  QDs	  -­‐4	   32.00	  
15	  nM	  Water	  Soluble	  QD-­‐PEG/tert-­‐amine	  QDs-­‐5	   30.12	  
Mean	   30.35	  
Std	  Dev	   1.40	  
Std	  Error	   0.63	  
Water	  Soluble	  CdSe	  QDs	  (unfunctionalized)	   (-­‐10)	  to	  (-­‐30)44	  
 
 
 
 The zeta potential values of ~30 mV suggest an electrostatic interaction between 
DNA and the conjugated QD-PEG/tert-amine is possible, via the net positive charge of 
the conjugated QD and anionic DNA species. The stoichiometric ratio of DMAPA was 
increased as much as possible in an attempt to increase the charge, but large increases 
caused loss of stability and aggregation. To investigate the ability of positively 
functionalized CdSe/ZnS QDs to bind DNA, the plasmid pEGFP-Rab5 was used. 
 
3.5 Plasmid DNA Replication and Characterization 
 The plasmid DNA used in this work was pGFP-EEA1 purchased from Addgene, 
which encodes for an early endosomal marker fused to GFP. Because cells successfully 
transfected with pGFP-EEA1 are expected to express visible green fluorescence (early 
endosomes), this plasmid was used as a reporter gene in lieu of therapeutic DNA. This 
allowed for an easy confirmation of successful transfection. Stock pDNA was purified 
from E. coli (described in Chapter 2), then confirmed by digestion with restriction 
endonucleases XbaI, and a combination of XhoiI and EcorRI. These endonucleases cleave 
49 
the DNA at specific sites into fragments with a known size. The resulting fragments were 
then characterized via electrophoresis (Figure 3.6). The size of the fragments in each 
band was estimated using a standard DNA ladder, indicating the plasmid from adgene 
replicated was the correct plasmid predicted.  
 
 
Figure 3.6. Electrophoretic Analysis of pDNA after Restriction Endonuclease Digestion. 
pGFP-EEA1 was digested in 2 ways: with XbaI to linearize the plasmid (9,085 base 
pairs), double digestion with XhoI and EcoRI to cut the plasmid into 2 bands produced 2 
fragments (6,580 and 2,505 base pairs). The uncut plasmid can also be seen in the top 
lane in the linear, knicked and supercoiled (left to right) pattern of uncut plasmids. 
 
 
 
3.6 Characterization of pDNA and QD-Conjugate Interactions 
 The interactions of pDNA with QD-PEG/tert-amine was evaluated through 
electrophoretic gel-shift assay to investigate the ability of QD conjugates to complex 
pDNA (i.e. slower gel migration rates vs. uncomplexed pDNA). Preliminary evaluation 
confirmed the presence of pDNA interaction with conjugated QDs. QDs and pDNA were 
added together to incubate at RT for ~30 mins before being loaded into each well. For 
this trial, an excess of QDs was combined with a low molar amount of pDNA that could 
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be visualized with SYBR green (detection limit ~1-2 ng45). The result seen in Figure 3.7, 
Comparing the ability of in-house synthesized QDs and commercial QDs to bind pDNA  
showed that QDs made in-house interacted with DNA, holding DNA within the well of 
the gel (Figure 3.7).  While similarly functionalized commercial QDs were not able to 
complex pDNA. 
 
Figure 3.7. Interaction of pDNA with QD-tert-amine. Lane 1-3: 1-~50 ng, 2-~100 ng, 3-
~500 ng pDNA incubated for 30 mins with 10 µL of 250 nM commercial QDs 
functionalized with DMAPA, Lane 4,5: 10 µL of 250 nM in-house synthesized QD-
PEG/tert-Amine was incubated with with 50 ng or, 100 ng  pDNA, Lane 6: pDNA alone 
(some bleedover from commercial QD in Lane 7), Lane 7: Commercial QDs 
functionalized with DMAPA, Lane 8: In-house QD-tert-amine. This gel shows pDNA is 
retained within the well when incubated with in-house QD-tert-amine, but not when 
incubated with commercial QDs functionalized with DMAPA. QDs (red); pDNA (green). 
 
 
 
The electrophoretic gel-shift assay demonstrated that commercial QDs had little-
to-no electrostatic attraction to pDNA, even after functionalization with DMAPA to 
increase net positive charge. This may have been caused by interactions with surface 
moieties; however, we are unable to fully evaluate the interactions due to the proprietary 
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nature of the commercial QDs (the identity of water-solubilizing coating of the 
commercial QDs are not available). DNA-QD complexation was successful in early trials 
with in-house QDs (Figure 3.7). In-house QDs retained the pDNA within the gel wells. 
Further trials were performed to optimize this interaction and attempt to complex an 
average of one pDNA on the surface of each QD. Future work with commercial QDs was 
abandoned at this point since they did not appear to complex pDNA. 
Figure 3.8, demonstrates the effect of increasing the amount of activator in the 
QD-diamine conjugation in an attempt to increase the net positive charge on QD-tert-
amine conjguates. Preliminary experiments bound DNA, but did not indicate the limit of 
how much pDNA could be bound (Figure 3.8A, 150,000 mole DMTMM: 1 mole QD) 
due to the DNA being retained in all trials. Later experiments demonstrated increased  
pDNA:QD interaction with increasing diamine functionalization. By increasing the 
DMTMM ratio, more carboxyl groups could be activated and more positive charge could 
be imparted onto the QDs. This increae in charge could lead to increased condensation of 
pDNA onto each QD. At a DMTMM ratio of 375,000 DMTMM:QD the conjugation was 
able to bind a 1:1 molar ratio of QD:pDNA. Figure 3.8 establishes two main things: 1) 
the ~1:1 molar ratio pDNA:QD was possible and successful with a 375,000:1 
DMTMM:QD excess (C,lane 3), and 2) too much DMTMM, unexpectedly, was unable to 
increase the binding ability of DNA. This decrease in binding efficency with increase 
DMTMM may be due to the reaction mechanism reaching a limit to the amount of 
carboxly groups that can be stably activated in a single reaction. By activating too many 
with the intermediate, it may decrease the overall water solubility of the compound, 
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resulting in a preciptate obsreved with increased DMTMM (500,000:1 mol 
DMTMM:mol QD). 
 
 
Figure 3.8. Gel-Shift Assays of QD-pDNA complexation. QD was conjugated to 
DMAPA using increasing amounts of activator (DMTMM) in an attempt to increase the 
overall positive charge of each QD-tert-amine conjugate. Each QD conjugate was 
incubated with ~10 ng of pDNA (green) for 30 min. In all trials, 10 ng of DNA was used 
and the amount of QD-tert-amine was decreased. In A, QD:DNA molar ratios were 
higher than needed, indicating we could lower the mol QD used in each trial. For B the 
QD reached the maximum capacity it could hold with a 2:1 mols QD: mols pDNA. In an 
attempt to increase this, higher DMTMM concentrations were used until a 1:1 mol ratio 
of pDNA:QD was attained in lane 3, C.  
 
 
 
The fluorescence intensity of QD-PEG/tert-amine dropped significantly vs. 
unfunctionalized QDs, which appeared to be correlated with repeated activation using 
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DMTMM in each step. To prevent this, functionalization with PEG and DMAPA was 
performed simultaneously to reduce the exposure of QDs to DMTMM. The successful 
reaction of QDs with both PEG and DMAPA was confirmed to bind the same amount of 
DNA as QDs produced in the 2-step reaction. 
 
3.7 Functionalization of Diamine/PEG QDs to Wheat Germ Agglutinin 
 With QD-PEG/tert-amine binding pDNA effectively at a 1:1 molar ratio the next 
conjugation was to biofunctionalize QDs with WGA. Wheat germ agglutinin (WGA) has 
been previously shown to bind to the nuclear membrane of the cell46, which is why it was 
chosen for this work. WGA is a sugar-binding protein (lectin) that our lab suspects could 
aid the trafficking of QD vectors through early endosomes, into the Golgi apparatus, 
through the endoplasmic reticulum and, potentially, into the nucleus. To exploit this 
pathway, WGA was conjugated to maleimide-activated QD-PEG/tert-amine at a ~1:1 
ratio (1WGA:1QD-PEG/tert-amine). To conjugate WGA to the QD-PEG/tert-amine two 
steps were required 1) maleimide was conjugated to the QD-PEG/tert-amine (Figure 2.3) 
and 2) a maleimide reaction with the free sulfhydryl in cysteine groups on WGA. There 
are 4 free sulfhydryl groups within WGA. These groups are located close together in both 
subunits of WGA. Stoichiometry was closely monitored to prevent aggregation of 
multivalent products. If the QD were to react with one of these groups, steric hindrance is 
expected to hinder reaction with a second free sulfhydryl, decreasing the likelihood of a 
multivalent product. However, a second attachment of WGA is still possible.  
 Confirmation of WGA conjugation proved challenging, and ultimately 
unsuccessful. Confirmation of WGA to the QD-PEG/tert-Amine QD conjugate was 
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attempted using a protein assay (fluorescamine assay). However, PMAL-d on the QD 
surface exhibited high background, decreasing the sensitivity of this method. Circular 
dichroism (CD) spectroscopy was also used to verify the presence of secondary structures 
in WGA. Being mostly alpha helices, WGA alone exhibited the expected characteristic 
peak dip signal (Figure 3.9). While the expected spectral characteristics were present, the 
WGA concentration of purchased WGA was much higher (13 µM to 130 nM) than our 
QD-WGA conjugates (10-15 nM or lower). This method was not sensitive enough to 
obtain reliable spectra at these concentrations, and performing larger scale reactions at 
this time was not feasible due to time constraints. 
 
Figure 3.9. Circular Dichroism Spectroscopy of WGA. WGA and QDs were evaluated on 
a CD spectraphotometer to determine if the technique could be used to test for presence 
or absence of WGA on QD conjugates. While QD-PEG/tert-amine showed little more 
than a baseline signal. The WGA signal was almost undectectable at 130 nM 
concentrations, 10x the theoretical amount in our WGA-QD conjugates. 
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3.8 Intracellular Tracking of WGA-QD Conjugates 
 The next step was to treat cells with QD-WGA conjugates to investigate 
intracellular trafficking. Initial incubations with QD-WGA conjugates were used to give a 
preliminary indication of cellular internalization (Figure 3.10). QD-WGA conjugates 
were incubated with a 1:1 molar ratio pDNA for 30 min before incubation with HeLa 
cells for 4 hours. After 4 hours, the cells were fixed and treated with fluorescent Hoechst 
dye (nuclear label). The QDs were internalized and localized around the nucleus (Figure 
3.10). However it is inconclusive if cellular location was from QDs exploiting the 
proposed pathway (EE→Golgi→ER→nucleus) or if QDs localized within lysosomes, 
which are also perinuclear. Additional experiments to investigate cellular localization 
were needed. These trials were performed with and without the presence of pDNA 
complexed to the QD surface, but the addition of pDNA had little-to-no effect.  
 
 
Figure 3.10. Internalization of WGA-QD Complexes with HeLa Cells.1:1 mol QD:mol 
WGA (A-E), 1:5 mol QD:mol WGA (F-J) . HeLa cells were incubated with QD-WGA 
complexes (red) for 4 hours and counterstained with Hoeschst (blue). These trials 
demonstrated the intracellular location of QD-WGA complexes. There was little to no 
difference in the amount of WGA (1:1 or 1:5) incubated with HeLa. The QDs (A,F) were 
overlaid with Hoeschst dye (B,G) to create a combination of only fluorescence (C,H) 
before being combined with differential interference contrast images (DIC, D,I) to give a 
full representation of the cell (E,J). 
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 The aforementioned intracellular trafficking experiment was repeated with the 
QD-WGA conjugates using Immunocytochemistry (ICC) to label the Golgi apparatus. 
Analysis of these images revealed little colocalization between the Golgi apparatus and 
QD-WGA (Figure 3.11). Images were subjected to Manders’ colocalization analysis, 
which returned an MQD value (red pixels overlapping green pixels) of only 0.327. The 
smaller value agreed with this initial view of little colocalization, indicating many QDs 
were not in the Golgi apparatus.  
 Experiments to investigate co-localization with lysosomes indicated high 
localization with the lysosome (Figure 3.12). While this is positive results of QDs 
localization within the cell, it showed that the QDs were likely not following the 
proposed pathway through the Golgi apparatus, but being degraded by lysosomes. The 
degree of overlap between the Golgi apparatus:QD and Lysosome:QD was 0.327 and 
0.903 respectively.  Unfortunately, was not a significant overlap between QD-WGA 
conjugates and the Golgi apparatus, which indicates that WGA conjugation was likely 
unsuccessful. 
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Figure 3.11. Co-localization of QD-WGA Complexes with the Golgi Apparatus. N2A 
cells were labeled with Hoechst (A), QDs (B) and a Golgi marker (C) then visualized 
with an overlay of the QDs and Golgi marker (D), DIC image of the cells (E) and a 
compilation of all 4 images (F). 
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Figure 3.12. Co-localization of QD-WGA Conjugates with Lysosomes in N2a Cells. QDs 
(A) and Lysotracker (B)were overlaid (C) and combined with a DIC image of the cells 
(D) to create a full view of the cell. Lysosomal marker (lysotracker) co-localized within 
the cell to a high degree, visualized as yellow when red is overlaid with green.  
 
  
3.9 Conclusions and Future Works 
This project explored the ability to use bioconjugated WGA-QDs as non-viral 
gene therapy vectors. Although additional information is required to determine if WGA 
can be used as a nuclear targeting agent for DNA delivery, these initial attempts have 
demonstrated the optimization of CdSe QD synthesis; successful ZnS coating for higher 
quality, photostable QDs; successful water solubilization techniques; functionalization of 
QDs to increase DNA binding, and carefully considered conjugation schemes. WGA 
conjugation was performed, but more careful analysis to confirm WGA conjugation is 
necessary.  Preliminary intracellular trafficking experiments have been completed, but 
additional characterization is necessary for conclusive discussion as to if the localization 
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to the lysosome was intrinsic in QD-WGA conjugates or if it was due to a lack of WGA 
conjugation. 
Many more studies can be done to increase the endocytic selectivity and stability 
of these QDs for gene therapy applications. Herein, our lab has demonstrated that the 
quality CdSe QDs cores were increased with each trial. The successive ionic layer 
adsorption and reaction (SILAR) method demonstrated an increase of fluorescence and 
slight increase in maximum fluorescence emission peak. The largest hurdle in this work 
was water solubilization of the synthesized QDs. This step took much longer than 
anticipated, and even when successful the amphiphilic polymer method did not produce 
QDs with consistent water solubility. Other ligands or amphiphilic polymers can be used 
to optimize the water solubilization of these QDs. Current work focuses on possible water 
solubilization through the use of bidentate ligand exchange methods in place of 
amphiphilic polymer coatings. While later trials of QD-WGA conjugation resulted in 
possible lysosomal degradation, it may have been due to the instability of the polymer 
causing issues when reacted in subsequent conjugations, causing many trials to 
precipitate out of solution. The stability of the QDs in water is the prime concern for 
conjugation validity. Current work is focused on developing more stable water-soluble 
QDs using functionalized lipoic acid as a ligand reagent. 
A second major concern is the degradation of Cd-based QDs in live cells. 
Trafficking of these Cd-based QDs to the acidic environment of the lysosomes could 
result in the degradation of the metallic nanocrystals, leading to the release of Cd+2 ions, 
which are toxic. The use of CdSe QDs, while being the most popular QD composition in 
biomedical research, has many alternatives. Indium is one of the more common 
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alternatives that maintains a high degree of fluorescence intensity without the use of 
cadmium, mitigating toxicity. Current work is underway to investigate indium-based core 
synthesis.  
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